Talon Therapeutics Inc (fka TLON)

[upanddown66]

revenue marqibo 1.Q 2015 1.9 million vs 1.5 in 2014

see SPPI data from 05/08/2015 1.Quarter numbers

THREE MONTHS ENDED MARCH 31, 2015 VERSUS 2014
Total Revenues
Three months ended March 31,
2015 2014 $ Change % Change
($ in millions)
Product sales, net:
FUSILEV $ 20.2 $ 22.2 $ (2.0 ) (9.0 )%
FOLOTYN 9.3 10.1 (0.8 ) (7.9 )%
ZEVALIN 4.2 6.3 (2.1 ) (33.3 )%
MARQIBO 1.9 1.5 0.4 26.7 %
BELEODAQ 2.8 - 2.8 - %
$ 38.4 $ 40.1 $ (1.7 ) (4.2 )%
License fees and service revenue 0.2 - 0.2 - %
Total revenues $ 38.6 $ 40.1 $ (1.5 ) (3.7 )%